Quinn, David I.
Stricker, Phillip D.
Kench, James G.
Grogan, Judith
Haynes, Anne-Maree
Henshall, Susan M.
Grygiel, John J.
Delprado, Warick
Turner, Jennifer J.
Horvath, Lisa G.
Mahon, Kate L.
Funding for this research was provided by:
Cancer Institute NSW (10/TPG/1-04)
Prostate Cancer Foundation of Australia (CSA 0515)
Movember Foundation (CSA 0515)
Australian Department of Health and Ageing
Article History
Received: 24 January 2019
Revised: 23 July 2019
Accepted: 26 July 2019
First Online: 14 August 2019
Competing interests
: The authors declare no competing interests.
: The study was approved by the St Vincent’s Research Ethics Committee (12/231) and performed in accordance with the Declaration of Helsinki.
: This study was funded by Cancer Institute New South Wales (10/TPG/1–04) and the Australian Department of Health and Aging (APCRC-NSW). Dr Kate Mahon is funded by a Movember Clinician Scientist Award awarded through Prostate Cancer Foundation of Australia’s Research Program (CSA 0515) and an Australian and New Zealand Urogenital and Prostate Cancer Clinical Trials Group/Mundipharma Clinical Research Fellowship.
: All the data analysed supporting the study results can be found at the Garvan Institute for Medical Research, Sydney Australia.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).